Form D · Biotechnology
Sinopia Biosciences, Inc.
San Diego, CA · CIK 0002145708
Offering snapshot reported Jul 16, 2026 · SEC filing
- Reported sold
- $2.82M Offering amount: $4.25M
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 29, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2026 | Initial | $2,818,079 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-591094
Source: Form D, filed Jul 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aarash Bordbar | Director, Executive |
| Iman Famili | Director |
| Bernhard Palsson | Director |
| Arthur T Suckow | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3210 Merryfield Row
San Diego, CA, 92121
Phone: 408-205-1008
San Diego, CA, 92121
Phone: 408-205-1008